Epigral Limited

BSE: EPIGRAL543332ISIN INE071N01016

Commodities
Specialty Chemicals
BSE 1000

BSE listing

Share price

₹1,106.00+3.40 (+0.31%)

as of 18 Sep 2026

52W high: ₹1,807.95
52W low: ₹806.20
Off 52W high: -38.83%
1M return: +2.52%
3M return: -1.95%
6M return: +29.77%
1Y return: -37.94%
20D avg volume: 3,817
50 DMA: ₹1,133.18
200 DMA: ₹1,129.47

Key ratios Consolidated

Market cap: ₹4,771 Cr
Current price: ₹1,106.00
52W high / low: ₹1,807.95 / ₹806.20
Face value: ₹10.00
P/E: 17.61
P/B: —
EPS (TTM): ₹62.82
Book value / share: —
ROE: —
ROCE: 14.80%
Operating margin: —
Net margin: —
Debt / equity: 0.25
Net debt: ₹557.97 Cr
Interest cover: 5.75
Dividend yield: 0.45%
Dividend / share (TTM): ₹5.00
Payout: 7.96%
Cash conversion cycle: 73.1 days

About

In plain English

Epigral is a chemical manufacturer that makes the basic building blocks for a huge range of everyday products. They produce caustic soda, which is used to make everything from aluminium to soap, and caustic potash, used in fertilizers and agrochemicals. But their real focus is on more advanced specialty chemicals: they make CPVC resin, the tough plastic used in hot-water pipes and plumbing fixtures (sold to pipe makers like Astral Pipes), and epichlorohydrin, a key ingredient in wind turbine blades, car parts, and strong adhesives (sold to companies like Westlake Epoxy and Kukdo Chemical). They also produce chloromethanes, used as solvents in pharmaceuticals and to make refrigerant gases, and hydrogen peroxide, used to bleach paper and textiles. Epigral makes money by manufacturing and selling these chemicals to industrial customers in India and globally, with a growing emphasis on higher-value specialty products.

AI-generated summary, written from the company's own filings and disclosures. Every figure elsewhere on this page comes from exchange data, not from a model. See our editorial standards. Generated 8 Jul 2026.

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	705.36	736.16	597.12	587.36	606.54	627.63	645.24	626.06	651.20	524.63	471.52	478.15
	4.10	-0.57	5.56	1.74	8.25	3.40	3.86	5.55	2.40	1.52	2.46	1.00
	576.28	625.07	548.08	519.15	508.06	499.97	495.57	507.20	522.50	413.31	399.82	423.02
	430.18	410.17	413.45	348.85	318.19	323.26	329.07	330.59	339.48	272.88	276.43	240.86
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	36.70	36.54	31.61	31.47	30.04	31.00	29.09	26.99	27.40	25.52	22.50	20.83
	7.22	15.80	10.95	21.84	23.37	11.77	0.07	27.32	14.25	13.69	20.19	21.27
	42.90	41.69	42.75	42.31	41.54	33.95	32.91	32.25	33.45	30.38	30.88	31.51
	96.42	106.02	104.64	96.03	94.04	94.33	70.11	56.88	57.74	—	48.29	47.43
	133.18	110.52	54.60	69.95	106.73	131.06	153.53	124.41	131.10	112.85	74.16	56.13
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	133.18	110.52	54.60	69.95	106.73	131.06	153.53	124.41	131.10	112.85	74.16	56.13
	34.00	28.59	15.45	18.43	53.68	44.44	49.99	43.88	45.09	36.18	24.85	17.95
	99.74	80.95	39.11	51.22	160.69	86.89	103.63	81.30	85.87	77.28	49.08	38.00
	23.12	18.76	9.07	11.87	37.25	20.14	24.25	19.57	20.67	18.60	11.81	9.14
Key metrics
	183.30	168.01	108.30	134.10	171.64	176.78	186.51	183.98	178.80	156.92	125.23	108.91
	26.00%	22.80%	18.10%	22.80%	28.30%	28.20%	28.90%	29.40%	27.50%	29.90%	26.60%	22.80%
	14.10%	11.00%	6.50%	8.70%	26.50%	13.80%	16.10%	13.00%	13.20%	14.70%	10.40%	7.90%
	—	4.50%	—	3.40%	—	5.40%	—	—	—	—	—	—
	16.30%	17.30%	-7.50%	-6.20%	-6.90%	19.60%	36.80%	30.90%	—	—	—	—
	-37.90%	-6.80%	-62.30%	-37.00%	87.10%	12.40%	111.10%	113.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	2,626	2,527	2,550	1,929	2,188	1,551
	10.83	14.98	15.21	6.51	7.98	4.11
	2,269	2,200	2,025	1,645	1,674	1,172
	1,603	1,491	1,322	1,072	1,212	759.41
	0.00	0.00	0.00	—	—	—
	136.32	129.66	114.48	89.66	86.60	76.80
	55.81	71.96	53.27	73.49	65.50	44.27
	169.65	168.29	132.56	123.56	108.95	85.91
	403.11	400.73	371.44	—	175.17	203.57
	368.25	341.80	540.10	290.67	522.48	383.42
	0.00	0.00	0.00	0.00	0.00	0.00
	368.25	341.80	540.10	290.67	522.48	383.42
	96.47	8.79	183.40	94.88	169.17	130.64
	271.02	331.97	357.69	195.82	353.29	252.79
	62.82	76.95	84.68	47.13	85.03	60.84
Key metrics
	593.71	582.05	725.93	487.72	696.93	513.60
	22.61%	23.00%	28.50%	25.30%	31.80%	33.10%
	10.32%	13.10%	14.00%	10.20%	16.10%	16.30%
	—	14.80%	22.30%	—	—	—
	—	-0.90%	32.20%	-11.80%	41.10%	—
	—	-7.20%	82.70%	-44.60%	39.80%	—
	—	41.38	245.87	—	—	—
	—	1.31	1.23	—	—	—
	—	0.25	0.31	—	—	—
	—	557.97	565.94	—	—	—
	—	73.1	62.2	—	—	—
Balance sheet
	—	3,505	3,152	—	—	—
	—	826.69	775.24	—	—	—
	—	5.02	18.64	—	—	—
	—	416.53	232.32	—	—	—
	—	348.63	387.99	—	—	—
	—	47.94	15.69	—	—	—
	—	2,102	2,219	—	—	—
	—	259.70	185.68	—	—	—
	—	710.42	492.74	—	—	—
	—	562.99	584.58	—	—	—
	—	229.30	135.61	—	—	—
	—	333.69	448.97	—	—	—
	—	2,221	1,905	—	—	—
Cash flow
	—	435.53	440.56	—	—	—
	—	-354.67	-261.56	—	—	—
	—	-94.48	-163.54	—	—	—
	—	394.15	194.69	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	705.36	736.16	597.12	587.36	606.54	627.63	645.24	626.06	651.20	524.63	471.52	478.15
	4.10	-0.57	5.56	1.74	8.25	3.40	3.86	5.55	2.40	1.52	2.46	1.00
	576.28	625.07	548.08	519.15	508.06	499.97	495.57	507.20	522.50	413.31	399.82	423.07
	430.18	410.17	413.45	348.85	318.19	323.26	329.07	330.59	339.48	272.88	276.43	240.86
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	36.70	36.54	31.61	31.47	30.04	31.00	29.09	26.99	27.40	25.52	22.50	20.83
	7.22	15.80	10.95	21.84	23.37	11.77	0.07	27.32	14.25	13.69	20.19	21.27
	42.90	41.69	42.75	42.31	41.54	33.95	32.91	32.25	33.45	30.38	30.88	31.51
	96.42	106.02	104.64	96.03	94.04	94.33	70.11	56.88	57.74	—	48.29	47.48
	133.18	110.52	54.60	69.95	106.73	131.06	153.53	124.41	131.10	112.85	74.16	56.08
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	133.18	110.52	54.60	69.95	106.73	131.06	153.53	124.41	131.10	112.85	74.16	56.08
	34.00	28.59	15.45	18.43	-53.68	44.44	49.99	43.88	45.09	36.18	24.85	17.95
	99.18	81.93	39.15	51.52	160.41	86.62	103.54	80.53	86.01	76.67	49.31	38.13
	22.99	18.99	9.07	11.94	37.18	20.08	24.23	19.38	20.70	18.45	11.87	9.18
Key metrics
	183.30	168.01	108.30	134.10	171.64	176.78	186.51	183.98	178.80	156.92	125.23	108.86
	26.00%	22.80%	18.10%	22.80%	28.30%	28.20%	28.90%	29.40%	27.50%	29.90%	26.60%	22.80%
	14.10%	11.10%	6.60%	8.80%	26.40%	13.80%	16.00%	12.90%	13.20%	14.60%	10.50%	8.00%
	—	4.50%	—	3.40%	—	5.40%	—	—	—	—	—	—
	16.30%	17.30%	-7.50%	-6.20%	-6.90%	19.60%	36.80%	30.90%	—	—	—	—
	-38.20%	-5.40%	-62.20%	-36.00%	86.50%	13.00%	110.00%	111.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	2,626	2,527	2,550	1,929	2,188	1,551
	10.83	14.98	15.21	6.51	7.98	4.11
	2,269	2,200	2,025	1,645	1,674	1,172
	1,603	1,491	1,322	1,072	1,212	759.41
	0.00	0.00	0.00	—	—	—
	136.32	129.66	114.48	89.65	86.60	76.79
	55.81	71.96	53.27	73.49	65.50	44.27
	169.65	168.29	132.56	123.56	108.95	85.91
	403.11	400.73	371.44	—	175.12	203.57
	368.25	341.80	540.10	290.67	522.53	383.42
	0.00	0.00	0.00	—	—	—
	368.25	341.80	540.10	290.67	522.53	383.42
	96.47	8.79	183.40	94.88	169.17	130.64
	271.78	333.01	356.70	195.79	353.36	252.79
	62.99	77.19	84.45	47.12	85.04	60.84
Key metrics
	593.71	582.05	725.93	487.72	696.98	513.60
	22.61%	23.00%	28.50%	25.30%	31.80%	33.10%
	10.35%	13.20%	14.00%	10.10%	16.10%	16.30%
	—	14.80%	22.30%	—	—	—
	—	-0.90%	32.20%	-11.80%	41.10%	—
	—	-6.60%	82.20%	-44.60%	39.80%	—
	—	41.38	245.87	—	—	—
	—	1.31	1.24	—	—	—
	—	0.25	0.31	—	—	—
	—	557.97	565.94	—	—	—
	—	73.1	62.2	—	—	—
Balance sheet
	—	3,505	3,151	—	—	—
	—	826.69	775.24	—	—	—
	—	5.02	18.64	—	—	—
	—	416.53	232.32	—	—	—
	—	348.63	387.99	—	—	—
	—	47.94	15.69	—	—	—
	—	2,102	2,219	—	—	—
	—	259.70	185.68	—	—	—
	—	710.42	492.74	—	—	—
	—	562.99	584.58	—	—	—
	—	229.30	135.61	—	—	—
	—	333.69	448.97	—	—	—
	—	2,221	1,904	—	—	—
Cash flow
	—	435.53	440.56	—	—	—
	—	-354.67	-261.56	—	—	—
	—	-94.48	-163.54	—	—	—
	—	394.15	194.69	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +4.91%
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: -1.96%
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): +4.81%
Profit YoY (TTM): -36.96%

Consolidated

Sales CAGR 3Y: +4.91%
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: -2.05%
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): +4.81%
Profit YoY (TTM): -37.34%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 68.83%

Holder	Type	Holding	Previous	Change
Ashishbhai Natawarlal Soparkar	Promoter	14.65%	—	—
Patel Natwarlal Meghjibhai	Promoter	9.68%	—	—
Jayantibhai Meghjibhai Patel	Promoter	8.29%	—	—
Rameshbhai Meghjibhai Patel	Promoter	6.79%	—	—
Maulik Jayantibhai Patel	Promoter	5.19%	—	—
Patel Ankit Natwarlal	Promoter Group	4.44%	—	—
Anandbhai Ishwarbhai Patel	Promoter	4.21%	—	—
Bandhan Small Cap Fund	Public	2.95%	—	—
HSBC Mutual Fund - HSBC Value Fund	Public	2.56%	—	—
Taraben Jayantilal Patel	Promoter Group	2.34%	—	—
VLS Finance Ltd	Public	1.91%	—	—
Patel Karana Rameshbhai	Promoter Group	1.68%	—	—
Patel Kalpana Rameshbhai	Promoter Group	1.28%	—	—
Patel Natubhai Meghjibhai (HUF)	Promoter Group	1.13%	—	—
Disha Kevatkumar Vanani	Promoter Group	1.13%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Epigral Limited ('the Company') hereby informs that the officials of the Company are participating in Anand Rathi Annual Flagship Conference: G-200 Summit 2026 scheduled on 21.09.2026.16 Sep 2026 · Company Update / Analyst / Investor Meet
Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday, 03.09.202631 Aug 2026 · Company Update / Analyst / Investor Meet
Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.202618 Aug 2026 · Company Update / Analyst / Investor Meet
Epigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August, 20267 Aug 2026 · Company Update / Analyst / Investor Meet
Epigral Limited informs that the Company is having One-on-One Meeting with Investor / Analyst on Monday, 3rd august, 2026.30 Jul 2026 · Company Update / Analyst / Investor Meet
Epigral Limited submits Transcript of Conference Call discussing Q1 FY27 Results.30 Jul 2026 · Company Update / Earnings Call Transcript
Newpaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.202629 Jul 2026 · Company Update / Newspaper Publication
Newspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.202629 Jul 2026 · Company Update / Newspaper Publication
Audio Recording of Conference Call discussing Q1 FY27 Results held on Monday, 27th July, 2026 at 5.00 p.m.27 Jul 2026 · Company Update / Analyst / Investor Meet
Investor Presentation Q1 FY 27.27 Jul 2026 · Company Update / Investor Presentation
Press Release of Un-Audited Financual results - Q1FY27.27 Jul 2026 · Company Update / Press Release / Media Release
As part of the Company''s strategic growth and expansion initiatives, it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its ....27 Jul 2026 · Company Update / General
Outcome of Board Meeting held on Monday, 27th July, 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June, 2026.27 Jul 2026 · Board Meeting / Outcome of Board Meeting
UNAUDITED FINANCIAL RESULTS - 30.06.2026.27 Jul 2026 · Result / Financial Results
Epigral Limited''s reply to clarification sought by the Stock Exchange with reference to Movement in Volume.22 Jul 2026 · Company Update / General
Epigral Limited has informed the Exchange about Conference Call on Monday, 27th July, 2026 to discuss Q1 FY27 Results22 Jul 2026 · Company Update / Analyst / Investor Meet
The Exchange has sought clarification from Epigral Ltd on July 22, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.22 Jul 2026 · Company Update / Clarification
Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone ....22 Jul 2026 · Board Meeting / Board Meeting
Revised Credit Rating.14 Jul 2026 · Company Update / Credit Rating
Epigral Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.20269 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Epigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".7 Jul 2026 · Company Update / Acquisition
Epigral Limited submits Notice of Closure of Trading Window27 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on June 16, 2026.10 Jun 2026 · Company Update / Analyst / Investor Meet
Submission of Scrutinizer''s Report of 19th AGM held on 08.06.2026.9 Jun 2026 · AGM/EGM / AGM
Proceedings of 19th AGM held on 08.06.2026.8 Jun 2026 · AGM/EGM / AGM
Epigral Limited submit Review of CRISIL Ratings on the Bank Facilities of Epigral Limited.3 Jun 2026 · Company Update / Credit Rating
Annual Secretarial Compliance Report - 31.03.2026.26 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Postal Ballot - Scrutinizer''s Report and Outcome.20 May 2026 · AGM/EGM / Postal Ballot
Epigral Limited submits Newspaper Publication pertaining to 19th Annual General Meeting and Record Date for Dividend and E-Voting18 May 2026 · Company Update / Newspaper Publication
Epigral Limited informs about virtual particiaption in Conference on 20th May, 2026.18 May 2026 · Company Update / Analyst / Investor Meet
BRSR of F.Y. 2025-26.15 May 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report of F.Y. 2025-26.15 May 2026 · Others / Reg. 34 (1) Annual Report
Intimation of 19th AGM to be held on 08.06.2026.15 May 2026 · AGM/EGM / AGM
Newspaper Publication - 19th AGM to be held on 08.06.2026.14 May 2026 · Company Update / Newspaper Publication
Record Date for Dividend - 01.06.2026.14 May 2026 · Corp Action / Dividend/AGM
Intimation of One on One meeting on 15.05.2026.12 May 2026 · Company Update / Analyst / Investor Meet
Intimation of One-on-One Meeting through V.C. with Investor / Analyst on 8th May, 20266 May 2026 · Company Update / Analyst / Investor Meet
We hereby submits the transcript of Conference call discussing Q4 FY2026 results held on 02.05.2026.6 May 2026 · Company Update / Earnings Call Transcript
Newspaper Publication - Audited Financial Results.5 May 2026 · Company Update / Newspaper Publication
Audio Recording of Conference Call discussing Q4 FY2026 Results held on Saturday, 2nd May, 2026 at 4.30 p.m.3 May 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 5.0000	1 Jun 2026	1 Jun 2026	—
Final Dividend - Rs. - 3.5000	20 Jun 2025	21 Jun 2025	—
Interim Dividend - Rs. - 2.5000	7 Feb 2025	7 Feb 2025	—
Final Dividend - Rs. - 5.0000	2 Jul 2024	2 Jul 2024	—

Board meetings

27 Jul 2026 Board Meeting - Financial Results